Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Muyldermans, Serge" or (type any "bookEditor issueEditor" and editor="Muyldermans, Serge")

Add to list
- Journal Article
- A1
- open access
CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens (UGent) , Serge Muyldermans, et al.

(2021) ONCOIMMUNOLOGY. 10(1).
Add to list
- Journal Article
- A1
- open access
Development of a nanobody-based lateral flow assay to detect active Trypanosoma congolense infections

Joar E Pinto Torres, Julie Goossens, Jianzu Ding, Zeng Li, Shaohong Lu, Didier Vertommen, Peter Naniima, Rui Chen, Serge Muyldermans, Yann G-J Sterckx, et al.

(2018) SCIENTIFIC REPORTS. 8.
Add to list
- Journal Article
- A1
- open access
Structural basis for the high specificity of a Trypanosoma congolense immunoassay targeting glycosomal aldolase

Joar Pinto, Steven Odongo, Felicity Lee, Vaiva Gaspariunaite, Serge Muyldermans, Stefan Magez (UGent) and Yann G-J Sterckx

(2017) PLOS NEGLECTED TROPICAL DISEASES. 11(9).
Add to list
Functionalization of gold nanoparticles with nanobodies through physical adsorption

Julie Goossens, Hla Sein, Shaohong Lu, Magdalena Radwanska (UGent) , Serge Muyldermans, Yann G-J Sterckx and Stefan Magez (UGent)

(2017) ANALYTICAL METHODS. 9(23). p.3430-3440
Add to list
Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Ahmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, Kevin Van der Jeught, Serge Muyldermans, José Van Der Heyden (UGent) , Tony Lahoutte, Jan Tavernier (UGent) and Nick Devoogdt

(2017) MOLECULAR CANCER THERAPEUTICS. 16(12). p.2828-2839
Add to list
- Journal Article
- A1
An anti-proteome nanobody library approach yields a specific immunoassay for Trypanosoma congolense diagnosis targeting glycosomal aldolase

Steven Odongo, Yann GJ Sterckx, Benoit Stijlemans, Davita Pillay, Theo Baltz, Serge Muyldermans and Stefan Magez (UGent)

(2016) PLOS NEGLECTED TROPICAL DISEASES. 10(2).
Add to list
- Journal Article
- A1
Dromedary immune response and specific Kv2.1 antibody generation using a specific immunization approach

Rym Hassiki, Alain J Labro (UGent) , Zakaria Benlasfar, Cécile Vincke, Mahmoud Somia, Mohamed El Ayeb, Serge Muyldermans, Dirk J. Snyders and Balkiss Bouhaouala-Zahar

(2016) INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 93(Part A). p.167-171
Add to list
- Journal Article
- A1
- open access
Sortase a-mediated site-specific labeling of camelid single-domain antibody-fragments : a versatile strategy for multiple molecular imaging modalities

Sam Massa, Niravkumar Vikani, Cecilia Betti, Steven Ballet, Saskia Vanderhaegen, Jan Steyaert, Benedicte Descamps (UGent) , Christian Vanhove (UGent) , Anton Bunschoten, Fijs van Leeuwen, et al.

(2016) CONTRAST MEDIA & MOLECULAR IMAGING. 11(5). p.328-339
Add to list
Nanobody-based products as research and diagnostic tools

Thomas De Meyer (UGent) , Serge Muyldermans and Anna Depicker (UGent)

(2014) TRENDS IN BIOTECHNOLOGY. 32(5). p.263-270
Add to list
Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins

Thomas De Meyer (UGent) , Dominique Eeckhout (UGent) , Riet De Rycke (UGent) , Sylvie De Buck (UGent) , Serge Muyldermans and Anna Depicker (UGent)

(2014) PLANT MOLECULAR BIOLOGY. 84(1-2). p.83-93
Add to list
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

Miguel Lopez Cardoso (UGent) , Lorena Ibanez (UGent) , Silvie Van den Hoecke (UGent) , Sarah De Baets (UGent) , Anouk Smet (UGent) , Kenny Roose (UGent) , Bert Schepens (UGent) , Francis Descamps (UGent) , Walter Fiers, Serge Muyldermans, et al.

(2014) JOURNAL OF VIROLOGY. 88(15). p.8278-8296
Add to list
- Journal Article
- A1
Affinity is an important determinant of the anti-trypanosome activity of nanobodies

Guy Caljon, Benoit Stijlemans, Dirk Saerens, Jan Van Den Abbeele, Serge Muyldermans, Stefan Magez (UGent) and Patrick De Baetselier

(2012) PLOS NEGLECTED TROPICAL DISEASES. 6(11).
Add to list
- Journal Article
- A1
High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis

Benoit Stijlemans, Guy Caljon, Senthil Kumar A Natesan, Dirk Saerens, Katja Conrath, David Perez-Morga, Jeremy N Skepper, Alexandros Nikolaou, Lea Brys, Etienne Pays, et al.

(2011) PLOS PATHOGENS. 7(6).
Add to list
- Journal Article
- A1
- open access
Antibody fragments as probe in biosensor development

Dirk Saerens, Lieven Huang (UGent) , Kristien Bonroy and Serge Muyldermans

(2008) SENSORS. 8(8). p.4669-4686
Add to list
Parallel selection of multiple anti-infectome nanobodies without access to purified antigens

Dirk Saerens, Benoît Stijlemans, Toya Nath Baral, Giang Thanh Nguyen Thi, Ulrich Wernery, Stefan Magez (UGent) , Patrick De Baetselier, Serge Muyldermans and Katja Conrath

(2008) JOURNAL OF IMMUNOLOGICAL METHODS. 329(1-2). p.138-150
Add to list
- Conference Paper
- P1
Camel antibodies for therapeutic and research applications

Cecile Vincke, Mireille Pellis, Toya Nath Baral, Benoit Stijlemans, Sergei Tillib, Ulrich Rothbauer, Heinrich Leonhardt, Katja Conrath, Stefan Magez (UGent) , U Wernery, et al.

(2008) Proceedings of the international camel conference : recent trends in camelids research and future strategies for saving camels. p.71-75
Add to list
Traitement expérimental de la trypanosomiase africaine par le facteur trypanolytique humain combiné à un nanocorps

Toya Nath Baral, Stefan Magez (UGent) , Benoit Stijlemans, Katja Conrath, Benoit Vanhollebeke, Etienne Pays, Serge Muyldermans and Patrick De Baetselier

(2006) MS. MÉDECINE/SCIENCES. 22(11). p.914-916
Add to list
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor

Toya Nath Baral, Stefan Magez (UGent) , Benoît Stijlemans, Katja Conrath, Benoit Vanhollebeke, Etienne Pays, Serge Muyldermans and Patrick De Baetselier

(2006) NATURE MEDICINE. 12(5). p.580-584
Add to list
Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies : African trypanosomes as paradign

Benoît Stijlemans, Katja Conrath, Virna Cortez-Retamozo, Hoang Van Xong, Lode Wyns, Peter Senter, Hilde Revets, Patrick De Baetselier, Serge Muyldermans and Stefan Magez (UGent)

(2004) JOURNAL OF BIOLOGICAL CHEMISTRY. 279(2). p.1256-1261

Academic Bibliography

CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Development of a nanobody-based lateral flow assay to detect active Trypanosoma congolense infections

Structural basis for the high specificity of a Trypanosoma congolense immunoassay targeting glycosomal aldolase

Functionalization of gold nanoparticles with nanobodies through physical adsorption

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

An anti-proteome nanobody library approach yields a specific immunoassay for Trypanosoma congolense diagnosis targeting glycosomal aldolase

Dromedary immune response and specific Kv2.1 antibody generation using a specific immunization approach

Sortase a-mediated site-specific labeling of camelid single-domain antibody-fragments : a versatile strategy for multiple molecular imaging modalities

Nanobody-based products as research and diagnostic tools

Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

Affinity is an important determinant of the anti-trypanosome activity of nanobodies

High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis

Antibody fragments as probe in biosensor development

Parallel selection of multiple anti-infectome nanobodies without access to purified antigens

Camel antibodies for therapeutic and research applications

Traitement expérimental de la trypanosomiase africaine par le facteur trypanolytique humain combiné à un nanocorps

Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor

Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies : African trypanosomes as paradign

Contents

Support

Contact